CAM-H2 effectively targets and treats HER2 positive brain lesions: a comparative preclinical study with Trastuzumab.

Research output: Unpublished contribution to conferencePoster

Original languageEnglish
DOIs
Publication statusPublished - 2 May 2019
EventEuropean Society of Medical Oncology - Breast 2019 - Berlin, Germany
Duration: 2 May 20194 May 2019
https://www.esmo.org/Conferences/Past-Conferences/ESMO-Breast-Cancer-2019

Conference

ConferenceEuropean Society of Medical Oncology - Breast 2019
Abbreviated titleESMO breast
CountryGermany
CityBerlin
Period2/05/194/05/19
Internet address

Cite this